Initial results from Oxford Covid-19 vaccine ‘encouraging’, say experts

(University of Oxford/PA)

Experts have hailed the initial results from the University of Oxford’s Covid-19 vaccine as “encouraging”, as data from the latest trial suggests it produces a strong immune response in older people.

The ChAdOx1 nCov-2019 vaccine has been shown to trigger a robust immune response in healthy adults aged 56-69 and people over 70 in phase two clinical trials.